LFTD Partners (LIFD, $0.26) was a top loser over the last three months, falling -4 to $0.26 per share. A.I.dvisor analyzed 212 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending April 8, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.